Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (351-360 of 2,089) with videos related to

Pageof 209
Sort By:
RMD Open|September 22, 2025
'Fast Ossifier' in diffuse idiopathic skeletal hyperostosis: a sex-modulated, heterogeneous phenotype with accelerated ossification and early trabecular declineEmilio Pariente-Rodrigo, Marta Martín-Millán, Giusi Sgaramella, et al.
RMD Open|September 26, 2025
Data-driven identification of subgroups in early rheumatoid arthritis: mortality and cardiovascular disease in a cohort from western NorwayChristian Lillebø Alsing, Jannicke Igland, Tone Wikene Nystad, et al.
RMD Open|August 19, 2025
Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension studyJoan T Merrill, Amit Saxena, Martin Aringer, et al.
RMD Open|August 5, 2025
Automated ultrasound system ARTHUR V.2.0 with AI analysis DIANA V.2.0 matches expert rheumatologist in hand joint assessment of rheumatoid arthritis patientsBill Aplin Frederiksen, Hilde Berner Hammer, Lene Terslev, et al.
RMD Open|August 8, 2025
Effectiveness and safety of the recombinant zoster vaccine in adult patients with systemic lupus erythematosus: a claims-based retrospective cohort study in the USASophie E Mayer, Sheryl A Kluberg, O'Mareen Spence, et al.
RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.
RMD Open|August 1, 2025
The equivocal opposite effects of lower and higher body mass index at diagnosis on radiographic joint damage progression in early rheumatoid arthritis: an inception cohort study over 15 yearsSofia Ajeganova, Kristina Forslind, Ingiäld Hafström
RMD Open|August 24, 2021
Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based surveyFrancesco Ursini, Jacopo Ciaffi, Luana Mancarella, et al.
RMD Open|May 25, 2021
Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western SwedenAnton Jonatan Landgren, Mats Dehlin, Lennart Jacobsson, et al.
RMD Open|July 5, 2025
Incidence and prevalence of ANCA-associated vasculitis in Oslo, Norway, applying different criteria-based case definitions: a population-based cohort studyKarin R Kilian, Cathrine Brunborg, Sigrun Skaar Holme, et al.
Pageof 209

Showing results (351-360 of 2,089) with videos related to

Sort By:
Pageof 209
RMD Open|September 22, 2025
'Fast Ossifier' in diffuse idiopathic skeletal hyperostosis: a sex-modulated, heterogeneous phenotype with accelerated ossification and early trabecular declineEmilio Pariente-Rodrigo, Marta Martín-Millán, Giusi Sgaramella, et al.
RMD Open|September 26, 2025
Data-driven identification of subgroups in early rheumatoid arthritis: mortality and cardiovascular disease in a cohort from western NorwayChristian Lillebø Alsing, Jannicke Igland, Tone Wikene Nystad, et al.
RMD Open|August 19, 2025
Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension studyJoan T Merrill, Amit Saxena, Martin Aringer, et al.
RMD Open|August 5, 2025
Automated ultrasound system ARTHUR V.2.0 with AI analysis DIANA V.2.0 matches expert rheumatologist in hand joint assessment of rheumatoid arthritis patientsBill Aplin Frederiksen, Hilde Berner Hammer, Lene Terslev, et al.
RMD Open|August 8, 2025
Effectiveness and safety of the recombinant zoster vaccine in adult patients with systemic lupus erythematosus: a claims-based retrospective cohort study in the USASophie E Mayer, Sheryl A Kluberg, O'Mareen Spence, et al.
RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.
RMD Open|August 1, 2025
The equivocal opposite effects of lower and higher body mass index at diagnosis on radiographic joint damage progression in early rheumatoid arthritis: an inception cohort study over 15 yearsSofia Ajeganova, Kristina Forslind, Ingiäld Hafström
RMD Open|August 24, 2021
Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based surveyFrancesco Ursini, Jacopo Ciaffi, Luana Mancarella, et al.
RMD Open|May 25, 2021
Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western SwedenAnton Jonatan Landgren, Mats Dehlin, Lennart Jacobsson, et al.
RMD Open|July 5, 2025
Incidence and prevalence of ANCA-associated vasculitis in Oslo, Norway, applying different criteria-based case definitions: a population-based cohort studyKarin R Kilian, Cathrine Brunborg, Sigrun Skaar Holme, et al.
Pageof 209